Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid

Clinical Biochemistry

Volumn 31, Issue 5, 1998, Pages 323-328

  Shaw, Leslie M ^a   Korecka, Magda ^a   Van Breeman, Richard ^b   Nowak, Irena ^a   Brayman, Kenneth L ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GLUCURONIDE; INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID; STEROID;

AREA UNDER THE CURVE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG GLUCURONIDATION; DRUG MECHANISM; DRUG MONITORING; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; LYMPHOCYTE PROLIFERATION; MASS SPECTROMETRY; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; GRAFT REJECTION; HUMANS; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; SENSITIVITY AND SPECIFICITY;

EID: 0032128130     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00050-2     Document Type: Conference Paper

References (22)

1. Sollinger H.W., Deirhoi M.H., Belzer F.O., Diethelm A.G., Kauffman R.S. RS-61433 - a Phase 1 clinical trial and pilot rescue study. Transplantation. 53:1992;428-432.
2. Bullingham R.E.S., Monroe S., Nicholls A., Hale M. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. J Clin Pharmacol. 36:1996;315-324.
3. Bullingham R.E.S., Nicholls A., Hale M. Pharmacokinetics of mycophenolate mofetil (RS-61443) a short review . Transplant Proc. 36:1996;315-324.
4. Takahashi K., Ochiai T., Uchida K., et al. Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients. Transplant Proc. 27:1995;1421-1424.
5. Hooftman L, Mroszczak E, Hale M. Pilot study of mycophenolate mofetil in patients following renal transplantation (NSK/MYCc 24/JPN, NSK/MYCc100/JPN). Syntex CL 6814.
6. Vanrenterghem Y, for the mycophenolate mofetil RCCT trial Group. The pharmacokinetic/pharmacodynamic relationship for MPA in renal transplantation - results of a randomized concentration-controlled trial (RCCT) of MMF. In: International Congress of Nephrology, Sydney, Australia, 1997; 1015.
7. Tsina I., Chu F., Hama K., et al. Manual and automated (robotic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in plasma. J Chromatog. 675:1996;119-129.
8. Haley C.J., Jaklitsch A., McGowan B., et al. Feasibility of an EMIT assay for mycophenolic acid in plasma. Ther Drug Monit. 17:1995;431. [abstract].
9. Dias V.C., Martens C., Zimmerman L., Yatscoff R.W., LeGatt D.F. Evaluation of the EMIT mycophenolic acid assay on the Cobas MIRA. Ther Drug Monit. 19:1997;563. [abstract].
10. Schutz E., Andreeva M., Niedmann P.D., et al. Mycophenolic acid determination after solid organ transplantation RP-HPLC and EMIT compared . Ther Drug Monit. 19:1997;566. [abstract].
11. Pawinski T., Jones K., Holt D.W. Validation of Behring Diagnostics EMIT to measure mycophenolic acid in human plasma. Ther Drug Monit. 19:1997;557. [abstract].
12. Schutz E, Andreeva M, Armstrong VW, et al. Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites. Trans Proc 1998; in press.
13. Staples M.A., Jiang C.C., Wieder-Bunger T., et al. An HPLC method compared to the EMIT mycophenolic acid assay. Ther Drug Monit. 19:1997;564. [abstract].
14. Nowak I., Shaw L.M. Mycophenolic acid binding to human serum albumin characterization and relationship to pharmacodynamics . Clin Chem. 41:1995;1011-1017.
15. Shaw L.M., Nowak I. Mycophenolic acid measurement and relationship to pharmacologic effects . Ther Drug Monit. 17:1995;685-689.
16. Shaw L.M., Mick R., Nowak I., et al. Mycophenolic acid pharmacokinetics in renal transplant patients with delayed graft function. J Clin Pharm. 38:1998;268-275.
17. Franklin T.J., Jacobs V., Jones G., Ple P., Bruneau P. Glucuronidation associated with intrinsic resistance to mycophenolic acid in human colorectal carcinoma cells. Cancer Res. 56:1996;984-987.
18. Sweeney M.J., Hoffman D.H., Esterman M.A. Metabolism and biochemistry of mycophenolic acid. Cancer Res. 32:1972;1803-1809.
19. Langman L.J., LeGatt D.F., Yatscoff R.W. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measuring IMP dehydrogenase activity. Clin Chem. 41:1995;295-299.
20. Nowak I., Shaw L.M. Effect of mycophenolic acid glucuronide on inosine monophosphate dehydrogenase activity. Ther Drug Monit. 19:1997;358-360.
21. Griesmacher A., Weigel G., Seebacher G., Muller M.M. IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide. Clin Chem. 43:1997;2312-2317.
22. Sintchak M.D., Fleming M.A., Futer O., et al. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Cell. 85:1996;921-930.